» Articles » PMID: 33535659

Interspecies Metabolic Complementation in Cystic Fibrosis Pathogens Via Purine Exchange

Overview
Journal Pathogens
Date 2021 Feb 4
PMID 33535659
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is a genetic disease frequently associated with chronic lung infections caused by a consortium of pathogens. It is common for auxotrophy (the inability to biosynthesize certain essential metabolites) to develop in clinical isolates of the dominant CF pathogen , indicating that the CF lung environment is replete in various nutrients. Many of these nutrients are likely to come from the host tissues, but some may come from the surrounding polymicrobial community within the lungs of CF patients as well. To assess the feasibility of nutrient exchange within the polymicrobial community of the CF lung, we selected and , two of the most prevalent species found in the CF lung environment. By comparing the polymicrobial culture of wild-type strains relative to their purine auxotrophic counterparts, we were able to observe metabolic complementation occurring in both and when grown with a purine-producing cross-species pair. While our data indicate that some of this complementation is likely derived from extracellular DNA freed by lysis of by the highly competitive , the partial complementation of purine deficiency by demonstrates that bidirectional nutrient exchange between these classic competitors is possible.

Citing Articles

Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery.

Baker E, Allcott G, Cox J NPJ Antimicrob Resist. 2025; 2(1):38.

PMID: 39843836 PMC: 11721438. DOI: 10.1038/s44259-024-00060-5.


Substrate identification of putative NCS1 and NCS2 nucleobase transporters in .

Kennelly C, Prindle A mBio. 2024; 15(12):e0243424.

PMID: 39475230 PMC: 11633122. DOI: 10.1128/mbio.02434-24.


Rescue of pyrimidine-defective through metabolic complementation.

Mahmud H, Garcia R, Garcia A, Baishya J, Wakeman C Microbiol Spectr. 2024; :e0422623.

PMID: 38990029 PMC: 11302043. DOI: 10.1128/spectrum.04226-23.


Environmental purines decrease Pseudomonas aeruginosa biofilm formation by disrupting c-di-GMP metabolism.

Kennelly C, Tran P, Prindle A Cell Rep. 2024; 43(5):114154.

PMID: 38669142 PMC: 11197132. DOI: 10.1016/j.celrep.2024.114154.


Enterococcus faecalis Antagonizes Pseudomonas aeruginosa Growth in Mixed-Species Interactions.

Tan C, Lam L, Biukovic G, Soh E, Toh X, Lemos J J Bacteriol. 2022; 204(7):e0061521.

PMID: 35758750 PMC: 9295543. DOI: 10.1128/jb.00615-21.


References
1.
Klarsfeld A, Goossens P, Cossart P . Five Listeria monocytogenes genes preferentially expressed in infected mammalian cells: plcA, purH, purD, pyrE and an arginine ABC transporter gene, arpJ. Mol Microbiol. 1994; 13(4):585-97. DOI: 10.1111/j.1365-2958.1994.tb00453.x. View

2.
Thammavongsa V, Kern J, Missiakas D, Schneewind O . Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med. 2009; 206(11):2417-27. PMC: 2768845. DOI: 10.1084/jem.20090097. View

3.
Machan Z, Taylor G, Pitt T, COLE P, Wilson R . 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother. 1992; 30(5):615-23. DOI: 10.1093/jac/30.5.615. View

4.
Saiman L, Siegel J . Infection control in cystic fibrosis. Clin Microbiol Rev. 2004; 17(1):57-71. PMC: 321464. DOI: 10.1128/CMR.17.1.57-71.2004. View

5.
Marcos V, Zhou-Suckow Z, Yildirim A, Bohla A, Hector A, Vitkov L . Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm. 2015; 2015:408935. PMC: 4397025. DOI: 10.1155/2015/408935. View